Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.
During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.
Disclosure of annual accounts or interim reports are disclosed on the Investor Calendar.
|Silent period and closed window||12.1.–12.2.2019|
|Financial statements release 1.1.–31.12.2018||12.2.2019|
|2018 annual report and financial statements||Week 13|
|Annual general meeting (preliminary date)||8.4.2019|
|Silent period and closed window||13.7.–13.8.2019|
|H1 2019 half-year report||13.8.2019|